SEC CIK 1523212
Rothe Christian E
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| GGGview stock → | 25,583.01 | 2024-03-29 |
| ROKview stock → | 10,428.694 | 2026-08-20 |
Position History — GGG
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — GGG
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2024-03-29 | Open-market sale | 10,000 | $91.02 | 25,583.01 |
| 2024-02-29 | Option exercise (derivative) | 19,012 | $0.00 | 39,380 |
| 2024-02-29 | Option exercise | 19,012 | $23.85 | 44,595.01 |
| 2024-02-29 | Open-market sale | 9,012 | $90.07 | 35,583.01 |
| 2024-02-28 | Option exercise (derivative) | 5,988 | $0.00 | 58,392 |
| 2024-02-28 | Open-market sale | 5,988 | $90.02 | 25,583.01 |
| 2024-02-28 | Option exercise | 5,988 | $23.85 | 31,571.01 |
| 2024-02-23 | Option exercise (derivative) | 15,000 | $0.00 | 64,380 |
| 2024-02-23 | Open-market sale | 15,000 | $90.04 | 25,583.01 |
| 2024-02-23 | Option exercise | 15,000 | $23.85 | 40,583.01 |
| 2024-02-16 | Grant / award (derivative) | 17,260 | $0.00 | 17,260 |
| 2023-02-17 | Grant / award (derivative) | 22,320 | $0.00 | 22,320 |
| 2022-02-18 | Grant / award (derivative) | 26,230 | $0.00 | 26,230 |
| 2021-03-15 | Option exercise (derivative) | 32,280 | $0.00 | 0 |
| 2021-03-15 | Open-market sale | 32,280 | $70.00 | 24,668.15 |
| 2021-03-15 | Option exercise | 27,060 | $24.93 | 51,728.15 |
| 2021-03-15 | Open-market sale | 27,060 | $70.00 | 56,948.15 |
| 2021-03-15 | Option exercise | 32,280 | $24.79 | 84,008.15 |
| 2021-02-12 | Grant / award (derivative) | 28,310 | $0.00 | 28,310 |
| 2020-07-23 | Option exercise (derivative) | 30,000 | $0.00 | 0 |
| 2020-07-23 | Option exercise | 26,700 | $16.61 | 41,197.55 |
| 2020-07-23 | Open-market sale | 21,976 | $55.00 | 19,221.55 |
| 2020-07-23 | Option exercise | 30,000 | $19.58 | 49,221.55 |
| 2020-07-23 | Open-market sale | 25,103 | $55.00 | 24,118.55 |
| 2020-02-14 | Grant / award (derivative) | 40,120 | $0.00 | 40,120 |
| 2019-02-15 | Grant / award (derivative) | 40,980 | $0.00 | 40,980 |
| 2018-02-16 | Grant / award (derivative) | 54,730 | $0.00 | 54,730 |
| 2017-12-13 | Option exercise (derivative) | 15,000 | $0.00 | 0 |
| 2017-12-13 | Open-market sale | 5,250 | $132.00 | 11,655.42 |
| 2017-12-13 | Open-market sale | 7,500 | $132.01 | 4,155.42 |
| 2017-12-13 | Option exercise | 15,000 | $49.73 | 16,905.42 |
| 2017-02-17 | Grant / award (derivative) | 21,920 | $0.00 | 21,920 |
| 2016-02-12 | Grant / award (derivative) | 26,460 | $0.00 | 26,460 |
| 2015-02-13 | Grant / award (derivative) | 10,760 | $0.00 | 10,760 |
| 2014-02-14 | Grant / award (derivative) | 9,020 | $0.00 | 9,020 |
| 2013-02-15 | Grant / award (derivative) | 10,000 | $0.00 | 10,000 |
| 2012-02-17 | Grant / award (derivative) | 8,900 | $0.00 | 8,900 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.